Evidence map›Paper›PMID 33798497›Full record

ArticleLancet (London, England)2021

Pandemic moves and countermoves: vaccines and viral variants.

Rogier W Sanders, Menno D de Jong

Registry-linked trialAbstract readComment
In one paragraph

Article in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04912700 (The Impact of Vaccination on Severity of Illness in COVID-19), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04912700 completednot on this map

The Impact of Vaccination on Severity of Illness in COVID-19: A Multicenter Cohort Study

TypeobservationalSponsorCorewell Health EastRan2021 to 2021Enrolled11,834ConditionsCovid19ArmsCOVID-19 vaccine
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Landscape and progress of global COVID-19 vaccine development.Human vaccines & immunotherapeutics · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Rogier W SandersDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam 1105 AZ, Netherlands; Department of Microbiology and Immunology, Weill Medical Center of Cornell University, New York, NY, USA. Electronic address: r.w.sanders@amsterdamumc.nl.
Menno D de JongDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam 1105 AZ, Netherlands.

Funding

Medical Research Council MC_PC_19055
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19VaccinesHumansPandemicsSARS-CoV-2Vaccines

Identifiers

PMID33798497
PMCPMC8009609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.